Lakewood-Amedex Biotherapeutics Inc.

LABT·NASDAQ·$0.74Share Price as of 11/2·$3MMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/14/26 10-QQuarter ended 03/31/2605/22/26

Disclosures

8-KCurrent report09/29/26 8-KCurrent report07/15/26 8-KCurrent report06/17/26 8-KCurrent report04/28/26

Prospectuses and Registrations

S-1Registration statement (IPO)09/18/26 424B3Prospectus08/17/26 424B3Prospectus06/22/26 424B3Prospectus06/22/26 424B3Prospectus05/26/26

Proxies

DEF 14ADefinitive proxy08/10/26 DEFA14AAdditional proxy materials08/10/26 PRE 14APreliminary proxy07/30/26

Ownership

SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/06/26 SC 13GBeneficial ownership06/23/26 Form 3Initial insider ownership05/06/26 Form 4Insider transaction05/06/26

Other

EFFECTRequest for effectiveness09/24/26 DRSDRS08/24/26 EFFECTRequest for effectiveness05/13/26 CORRESPCorrespondence with the SEC05/12/26 UPLOADLetter from the SEC05/08/26